Koninklijke DSM N.V. is a large company with a market capitalization of approximately €21.3 bln as of 3 Feb 2023, based on the latest data from the stock exchange. The company’s current market capitalization has decreased slightly since 2 Jan 2023 when it was €22.1 bln and 1 Feb 2023 when it was €21.3 bln. Over the past year, Koninklijke DSM N.V.’s market capitalization has seen fluctuations ranging from €10.9 bln to €16.8 bln from 8 Feb 2022 to 30 Jan 2023 respectively.
The company’s current price/earnings ratio (or P/E) stands at 19.1, which is significantly lower than its 50 day average of 119.819 and its 200 day average of 130.0145 respectively as of 3 Feb 2023, indicating that the company is undervalued at the moment relative to the broader market and potentially providing investors with an opportunity for long term growth potential at this time. Furthermore, Koninklijke DSM N.V.’s open price on 3 Feb 2023 stood at 118.4 and its previous close on 2 Feb 2023 was 118.5 meaning that share prices are relatively stable in comparison to recent days in addition to being undervalued overall which could make it a good buy right now for any investor looking for consistent returns over a longer period of time without too much risk involved or volatility in their portfolio performance overall
